-+ 0.00%
-+ 0.00%
-+ 0.00%

Wells Fargo Maintains Equal-Weight on Bristol-Myers Squibb, Raises Price Target to $65

Benzinga·07/31/2026 14:28:47
Listen to the news
Wells Fargo analyst Mohit Bansal maintains Bristol-Myers Squibb (NYSE:BMY) with a Equal-Weight and raises the price target from $60 to $65.